Biocon posted a consolidated net profit of Rs 660 crore for the third quarter ended December 31, 2023, driven by strong sales. The company's revenue also grew significantly.
New Delhi, Feb 8 (PTI) Biotech firm Biocon on Thursday reported a consolidated net profit of Rs 660 crore for the third quarter ended December 31, 2023, on the back of robust sales.
The company had reported a net loss of Rs 42 crore in the October-December period of last fiscal.
Total revenue rose to Rs 4,519 crore in the third quarter as against Rs 3,020 crore in the year-ago period, Biocon Ltd said in a statement.
"A key milestone this quarter was the successful conclusion of the transition of the acquired business by Biocon Biologics and a pre-payment of USD 200 million towards the acquisition-related debt reduction," Biocon Executive Chairperson Kiran Mazumdar Shaw said.
Steady market shares for key biosimilars in the US and EU were complemented by the emerging markets performance which saw a number of new product launches and tender wins, she added.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback